Turning Breakthrough Discoveries
into Medicines
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
Key Focus areas
We are developing a portfolio of drug candidates in the field of Neurodegenerative Disease, Immuno-Oncology and Rare Disease as well as developing Genomic-based target discovery platform for neurodegenerative target and biomarker discovery.
Meet the Team
1STBIO was founded by experienced veterans in the life science industry with an aim to assemble a team with scientific, clinical, and business expertise. Since its inception, seasoned professionals in their respective fields have joined together with an unwavering focus on discovering and developing therapeutics to improve patients’ lives.
Latest News
1ST Biotherapeutics, Inc., Announces Positive Phase I Data of c-Abl Inhibitor in Neurodegeneration
October 18, 2022
2022년 임시주주총회 소집공고(정정)
August 24, 2022
2022년 임시주주총회 소집공고
August 23, 2022
임시주주총회 기준일 공고
August 5, 2022
Where We’re Located
1ST Biotherapeutics, Inc.
338, Gwanggyojungang-ro, Gwanggyowoominewv, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
Suite A813, A1027, C603, C808, C809